For his innovation in the production and application of medical isotopes; for advancing the separation and purification of actinides and heavy elements; and for his leadership in the use of alpha emitters to save the lives of cancer patients.
For his broad scientific contributions and international reputation in aqueous chemistry and geochemistry; for his research into the structure, dynamics, and reactions at fluid–solid interfaces; and for his leadership and service to ORNL and the international scientific community.
For her leadership in the research and development of thin-film energy-storage systems; for advancing the understanding of the architectures, materials, and in-service dynamics of thin-film and 3D batteries; and for her leadership in the development of the lipon electrolyte.
Since 2001, Mike Simpson has been a group leader for the Nanofabrication Research Laboratory and theme leader in the Center for Nanophase Materials Sciences. His research focus includes noise biology, nano-enabled synthetic biology and controlled synthesis and directed assembly of carbon nanostructures.
For innovative research in nuclear structure physics, particularly in areas leading to a quantitative understanding of the excitation and decay of the elementary collective modes of nuclei, and for vision and scientific and technical leadership in building the Holifield Radioactive Ion Beam Facility into a forefront laboratory for nuclear science.
For distinguished research on the air/surface exchange of atmospheric trace gases and particles and their interactions with the Earth's biogeochemical cycles, and for pioneering developments in atmospheric sampling methodologies with special emphasis on the global mercury cycle.
For pioneering research in ecosystem theory, ecological modeling, error analysis, hierarchy theory, and landscape ecology and for the development of basic applications in risk assessment and regional environmental analysis.
For distinguished research in the field of risk assessment, including pharmacokinetic and pharmacodynamic models, interspecies extrapolation, and human exposure to dioxin and other background contaminants, and for significant contributions to environmental policy through pioneering investigations of the effectiveness of remediation technologies and through service on national and international advisory panels and boards